Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-09-23

Clinical Trial Update: Botulinum Toxin Injection to Prevent VT Storm [Phase 1]

View source ↗

Summary

Phase 1 clinical trial is evaluating botulinum toxin injections to prevent ventricular tachycardia storm; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Meshalkin Research Institute of Pathology of Circulation | Conditions: VT Storm | Phase 1 | Status: UNKNOWN